Independent audit confirms TraceLink's operational rigor and readiness to meet evolving customer and regulatory demands BOSTON, July 23, 2025 -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced the successful completion of its ISO 9001:2015 annual surveillance audit, expanding scope to include OPUS, the Orchestration Platform for Universal Solutions. The achievement reaffirms the company's commitment to delivering high-quality, reliable, and continuously-improving solutions and platform capabilities for organ
CHENGDU, China, July 23, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", HKEX: 6990) today announced that its partner, Windward Bio AG ("Windward Bio") has launched its Phase 2 POLARIS clinical study, assessing long-acting dosing of SKB378/WIN378 for people living with asthma. SKB378/WIN378 is a novel, recombinant fully human monoclonal antibody (mAb) that potently binds to the thymic stromal lymphopoietin (TSLP) ligand and inhibits the TSLP mediated signaling pathway by blocking the intera
STUART, Fla., July 23, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce it will host an exclusive half-day Summit on January 20, 2026, from 11:30 a.m. to 4:30 p.m. (CET) at the prestigious Belvedere Hotel in Davos, Switzerland, alongside the week of the World Economic Forum (WEF) Annual Meeting. The World Economic Forum, held each January in Davos, is one of the world's most prestigious gatherings of global leaders from business, government, academia, and civil society. It serves as a un
Fully Unmanned— CURECA™, the 100% Automated Diagnostic System Defining the Future Gold Standard, Debuts in Chicago, July 28–31 Unifying global diagnostic data - STAgora™, the big data platform set to transform the future of diagnostics Pilot partnerships to offer early access to the new diagnostic paradigm, with selected institutions engaged by year-end SEOUL, South Korea, July 23, 2025 -- Seegene Inc., a global leader in molecular diagnostics, announced today that it will unveil its fully automated PCR testing system, CURECA™, and its data analytics platform, STAgora™
[ 메디채널 김갑성 기자 ] Recognized for its AI-driven innovation, platform-agnostic product design, and exceptional customer-centric healthcare video solutions SAN ANTONIO, July 23, 2025 -- Frost & Sullivan is pleased to announce that AVer Information Inc. has received the 2025 Global Company of the Year Recognition in the medical-grade PTZ cameras industry for its outstanding achievements in technology innovation, healthcare-focused strategy execution, and customer impact. This recognition highlights AVer's consistent leadership in driving measurable outcomes, strengthening its market po
Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of HBM9378/WIN378 in patients with asthma, with an initial data readout expected in mid-2026 HBM9378/WIN378 has the potential to be the first-to-market long-acting anti-TSLP antibody with twice-yearly dosing for asthma Extended dosing intervals could reduce treatment burden and improve outcomes for patients with advanced respiratory diseases Global COPD clinical program planned to start in mid-2026 CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI, July 23, 2025 -- Harbour BioMed (the "
A Global Celebration Unites Dermatologists, Influencers, and Innovators in New York City to Mark 20 Years of the Iconic Skincare Brand NEW YORK, July 23, 2025 -- It's CeraVe-time to celebrate! CeraVe, the global skincare brand recommended by 80,000 dermatologists worldwide1, is celebrating a major milestone: 20 years of skin barrier authority, championing barrier health and delivering effective, skin identical ceramide and MVE solutions to provide accessible, therapeutic skincare solutions for everybody everywhere. Over the past two decades, CeraVe has catapulted from a
전 세계 피부과 전문의, 인플루언서, 혁신가들이 뉴욕에 모여 상징적인 스킨케어 브랜드의 20주년을 기념 뉴욕, 2025년 7월 23일 -- 세라비(CeraVe)의 시간을 축하할 때다. 전 세계 8만 명 이상의 피부과 전문의가 추천1하는 글로벌 스킨케어 브랜드 세라비가 피부장벽 전문 브랜드로서의 20년 여정을 기념하는 뜻깊은 이정표를 맞았다. 세라비는 그동안 피부장벽 건강의 중요성을 알리고, 피부 동일 세라마이드와 MVE를 활용한 효과적인 솔루션을 통해 모든 사람에게 접근 가능한 치료 기반 스킨케어를 제공해 왔다. 지난 20년 동안 세라비는 미국 내 피부과 전문의들만이 추천하는 비밀 브랜드에서 전 세계적인 현상으로 자리매김하며, 성별과 세대를 초월한 포용적 브랜드로 성장했다. 그 중심에는 변하지 않는 브랜드 인사이트가 있다. 대부분의 피부 문제는 피부 장벽 손상과 관련이 있으며, 이를 회복하고 유지하기 위해서는 피부 동일 세라마이드가 핵심이다. 이러한 인사이트는 세 가지 핵심 제품(모이스처라이징 크림, 모이스처라이징 로션, 하이드레이팅 클렌저)으로 출발해, 현재 90개 이상의 피부 장벽 강화 제품으로 확장해 글로벌 포트
STUART, Fla., July 23, 2025 -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce its donation of 60 new computers to the Diocese of Srikakulam, furthering educational opportunities and digital inclusion for children and families across the region. This contribution reflects Health In Tech's commitment to creating positive community impact that extends beyond health insurance and technology solutions. "The Diocese of Srikakulam deeply appreciates this generous gift from Health In Tech,"
KUALA LUMPUR, Malaysia, July 23, 2025 -- At the HIMSS APAC 2025 conference, GuidelineX made a powerful impact with its next-generation, AI-native Clinical Decision Support System (AI-CDSS). In her keynote, "Empowering Clinicians and Elevating Care: AI-Based Clinical Decision Support Systems," Chief Medical Officer Dr. Jenny Shao captured the attention of healthcare leaders and policymakers across the region. Dr. Shao addressed the limitations of traditional technologies in solving healthcare's biggest challenges—rising costs, resource shortages, and increasing demands